When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
PRVB - Provention Bio up 11% on positive teplizumab data
Provention Bio Inc.
Provention Bio (PRVB+10.6%) is up on a 4x surge in volume in reaction to follow-up data from a Phase 2 study, "At Risk" TN-10, evaluating teplizumab for preventing/delaying the onset of type 1 diabetes (T1D) in relatives of type 1 diabetics deemed "at very high risk" of developing the condition.
More news on: Provention Bio, Inc., Healthcare stocks news, Stocks on the move,